查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1942488

2026年全球乳房切片市場報告

Breast Biopsy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，乳房切片市場經歷了顯著成長，預計到2025年將達到15.3億美元，到2026年將達到16.5億美元，複合年成長率為7.5%。過去幾年成長要素包括：先進切片檢查系統應用有限、依賴傳統外科切片檢查技術、乳癌發病率上升、醫院和診斷中心基礎設施擴建以及超音波引導手術的普及。

預計未來幾年乳房切片市場將維持強勁成長，2030年市場規模將達到21.7億美元，複合年成長率（CAGR）為7.2%。預測期內的成長主要歸功於液態生物檢體和影像引導系統的技術進步、早期乳癌篩檢意識的提高、診斷中心和醫院的擴張、人工智慧和數據分析的日益普及，以及個人化和精準醫療方法的開發。預測期內的關鍵趨勢包括：微創切片檢查技術的日益普及、液態生物檢體技術的廣泛應用、影像引導切片檢查系統的成長、乳癌診斷和篩檢項目的擴展，以及對患者安全和檢體準確性的日益重視。

預計乳癌發病率的上升將推動乳房切片市場在未來持續成長。乳癌是一種起源於乳腺組織細胞的惡性腫瘤，若不及時治療，癌細胞會擴散至身體其他部位。乳癌發生率的上升與預期壽命延長、篩檢和診斷技術的進步以及公眾對該疾病認知度的提高等因素密切相關。乳癌乳房切片是指從可疑的乳房區域採集組織樣本，以確診並確定癌症的類型。例如，根據美國非營利組織Breastcancer.org預測，截至2025年10月，預計將有316,950名女性被診斷出患有侵襲性乳癌，同時也將報告約59,080例新的導管原位癌（DCIS）病例。因此，乳癌發生率的上升正在推動乳房切片市場的擴張。

乳房切片標記物市場的主要企業正致力於開發創新產品，例如超音波可見定位標記物，以提高病灶定位的準確性並減少乳房切片過程中標記物的移位。超音波可見定位標記物是一種可植入裝置，可在診斷影像過程中增強切片檢查部位的可見性，同時確保未來手術介入的穩定定位。例如，總部位於美國的乳房切片和立體定位技術供應商Mamotome於2023年8月推出了HydroMark Plus。這款乳房切片定位標記可提高超音波下病灶的可見性，幫助放射科醫師和外科醫師進行精準定位，同時最大限度地降低後續手術過程中標記物移位的風險。作為Mamotome HydroMark產品系列的最新成員，HydroMark Plus旨在提高手術可靠性，預計今年稍後在美國全國上市。其主要特點包括：超音波可見性高、在乳房組織內移動幅度小，以及與各種乳房攝影診斷和介入工作流程相容，有助於改善臨床療效和提高手術可靠性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球乳房切片市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 微創切片檢查技術的應用日益廣泛
    • 液態生物檢體技術的使用日益增多
    • 影像引導切片檢查系統的發展
    • 擴大乳癌診斷和篩檢項目
    • 更加重視病人安全和檢體準確性

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 診斷中心
  • 研究所
  • 腫瘤中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球乳房切片市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球乳房切片市場規模、對比及成長率分析
  • 全球乳房切片市場表現：規模與成長，2020-2025年
  • 全球乳房切片市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 切片穿刺針、導引系統、切片檢查、立體定位導絲、檢測試劑盒、液態生物檢體設備等。
  • 透過影像引導技術
  • 磁振造影（MRI）引導乳房切片、超音波引導乳房切片、乳房X光攝影引導立體定位切片檢查、電腦斷層掃描（CT）引導切片檢查及其他影像引導技術
  • 透過檢查程序
  • 乳房切片（針刺切片）、乳房切片（開腹手術）、乳房切片（液態生物檢體）
  • 透過使用
  • 醫院、診所、診斷中心和其他應用
  • 按類型細分：切片穿刺針
  • 核心切片穿刺針、細針穿刺（FNA）針、真空輔助切片穿刺針、自動切片穿刺針
  • 按類型細分：導引系統
  • 超音波引導系統、MRI引導系統、立體定位引導系統、斷層合成引導系統
  • 按類型細分：切片檢查
  • 可調節切片檢查台、專用切片檢查、相容影像診斷的切片檢查
  • 按類型細分：立體定位導線
  • 鉤線定位裝置、輻射導引定位線、磁性種子定位系統
  • 依類型細分：檢測試劑盒
  • 乳癌檢測試劑盒、生物標記檢測試劑盒、乳癌基因檢測套組
  • 按類型細分：液態生物檢體設備
  • 循環性腫瘤細胞（CTC）分離裝置、血漿DNA分離試劑盒、液態生物檢體分析系統
  • 按類型細分：其他類型
  • 切片檢查黏合劑、檢體採集和運輸裝置、病患管理系統

第10章 區域與國家分析

  • 全球乳房切片市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球乳房切片市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 乳房切片市場：競爭格局與市場佔有率，2024 年
  • 乳房切片市場：公司估值矩陣
  • 乳房切片市場：公司概況
    • Siemens Healthineers AG
    • Fujifilm Holdings Corporation
    • Becton Dickinson and Company BD
    • Koninklijke Philips
    • GE HealthCare Technologies Inc

第37章：其他領先和創新企業

  • Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年乳房切片市場：提供新機會的國家
  • 2030年乳房切片市場：充滿新機會的細分市場
  • 2030年乳房切片市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MBBIO04_G26Q1

A breast biopsy is a procedure in which a small sample of breast tissue is removed and examined under a microscope to determine whether it is cancerous or benign. It is usually performed when a lump or abnormality is detected through imaging or a physical exam, and it can be done using different techniques such as needle biopsy or surgical biopsy, often guided by imaging methods such as ultrasound or mammography.

The major types of breast biopsy products include biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others. Biopsy needles are specialized medical instruments designed to collect breast tissue samples for diagnostic evaluation. The image-guided technologies include MRI-guided breast biopsy, ultrasound-guided breast biopsy, mammography-guided stereotactic biopsy, CT-guided biopsy, and others, while the procedures involve needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. These are applied in hospitals, clinics, diagnostic centers, and other settings.

Tariffs are impacting the breast biopsy market by increasing the cost of imported biopsy needles, imaging guidance systems, and liquid biopsy instruments. Segments such as MRI-guided and stereotactic biopsy systems are particularly affected, with major manufacturing regions in Asia-Pacific, including China and India, facing higher import duties. This has led to elevated production and procurement costs, as well as delayed adoption in some regions. On the positive side, tariffs are encouraging local manufacturing, innovation in alternative devices, and investment in domestic production capacities.

The breast biopsy market research report is one of a series of new reports from The Business Research Company that provides breast biopsy market statistics, including breast biopsy industry global market size, regional shares, competitors with a breast biopsy market share, detailed breast biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the breast biopsy industry. This breast biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast biopsy market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to limited availability of advanced biopsy systems, reliance on traditional surgical biopsy methods, increasing breast cancer incidence, growing hospital and diagnostic center infrastructure, adoption of ultrasound-guided procedures.

The breast biopsy market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to technological advancements in liquid biopsy and imaging-guided systems, rising awareness of early breast cancer detection, expansion of diagnostic centers and hospitals, increasing integration of ai and data analytics, development of personalized and precision medicine approaches. Major trends in the forecast period include increasing adoption of minimally invasive biopsy procedures, rising use of liquid biopsy techniques, growth in imaging-guided biopsy systems, expansion of breast cancer diagnostic and screening programs, enhanced focus on patient safety and sample accuracy.

The growing prevalence of breast cancer is anticipated to support the expansion of the breast biopsy market going forward. Breast cancer is a malignant tumor that develops in the cells of breast tissue and may spread to other parts of the body if not treated in a timely manner. The increasing prevalence of breast cancer is linked to factors such as longer life expectancy, improved screening and detection techniques, and heightened awareness of the disease. Breast biopsy procedures are used to extract tissue samples from suspicious breast areas to confirm diagnoses and determine cancer characteristics. For example, in October 2025, according to Breastcancer.org, a US-based non-profit organization, an estimated 316,950 women were projected to be diagnosed with invasive breast cancer in 2025, along with approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast biopsy market.

Leading companies operating in the breast biopsy marker market are focusing on developing innovative products, such as ultrasound-visible site markers, to improve lesion localization and reduce marker displacement during breast biopsy procedures. An ultrasound-visible site marker is an implantable device designed to enhance visualization of biopsy sites during imaging while providing stable localization for future surgical interventions. For example, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, launched HydroMark Plus. This breast biopsy site marker improves lesion visibility under ultrasound, supporting accurate targeting by radiologists and surgeons while minimizing the risk of marker migration during subsequent surgical procedures. As the latest addition to Mammotome's HydroMark portfolio, HydroMark Plus is engineered for improved procedural reliability and was scheduled for nationwide availability in the US by year-end. Its key features include high ultrasound conspicuity, reduced movement within breast tissue, and compatibility with a wide range of breast imaging and interventional workflows, supporting improved clinical outcomes and procedural confidence.

In May 2024, Lunit Inc., a South Korea-based medical software company, acquired Volpara Health Technologies Ltd. for an undisclosed amount. Through this acquisition, Lunit enhances its portfolio with advanced breast imaging and analytics technologies, strengthening its capabilities in early cancer detection. Volpara Health Technologies Ltd. is a New Zealand-based provider of breast biopsy solutions.

Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.

North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The breast biopsy market consists of revenues earned by providing services such as biopsy procedures, consultations, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast biopsy market also includes sales of biodegradable tissue markers, and semi-automated and fully automated biopsy needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses breast biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Biopsy Needles; Guidance Systems; Biopsy Tables; Localization Wires; Assay Kits; Liquid Biopsy Instruments; Other Types
  • 2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy; Ultrasound Guided Breast Biopsy; Mammography Guided Stereotactic Biopsy; Computed Tomography (CT) Guided Biopsy; Other Image Guided Technologies
  • 3) By Procedure: Needle Breast Biopsy; Open Surgical Breast Biopsy; Liquid Breast Biopsy
  • 4) By Application: Hospitals; Clinics; Diagnostic Centers; Other Applications
  • Subsegments:
  • 1) By Biopsy Needles: Core Biopsy Needles; Fine Needle Aspiration (FNA) Needles; Vacuum-Assisted Biopsy Needles; Automatic Biopsy Needles
  • 2) By Guidance Systems: Ultrasound Guidance Systems; MRI Guidance Systems; Stereotactic Guidance Systems; Tomosynthesis Guidance Systems
  • 3) By Biopsy Tables: Adjustable Biopsy Tables; Specialty Biopsy Tables; Imaging-Compatible Biopsy Tables
  • 4) By Localization Wires: Hookwire Localization Devices; Radioguided Localization Wires; Magnetic Seed Localization Systems
  • 5) By Assay Kits: Breast Cancer Assay Kits; Biomarker Detection Kits; Genetic Testing Kits for Breast Cancer
  • 6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices; Plasma DNA Isolation Kits; Liquid Biopsy Analysis Systems
  • 7) By Other Types: Biopsy Adhesives; Specimen Collection and Transport Devices; Patient Management Systems
  • Companies Mentioned: Siemens Healthineers AG; Fujifilm Holdings Corporation; Becton Dickinson and Company BD; Koninklijke Philips; GE HealthCare Technologies Inc; Hologic Inc; Merit Medical Systems; Argon Medical Devices; Canon Medical Systems Corporation; Devicor Medical Products Inc; Planmed Oy; Menarini-Silicon Biosystems; Seno Medical Instruments Inc; Dilon Technologies Inc; INRAD Inc; Promaxo Inc; Cook Medical LLC; Boston Scientific Corporation; Stryker Corporation; Intact Medical Corporation; Scion Medical Technologies LLC; Galini SRL; Ethicon Surgical Technologies; Encapsule Medical Devices LLC; Cardinal Health Inc; Olympus Corporation; F Hoffmann-La Roche Ltd; Biocept Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Breast Biopsy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Breast Biopsy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Breast Biopsy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Breast Biopsy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Biopsy Procedures
    • 4.2.2 Rising Use Of Liquid Biopsy Techniques
    • 4.2.3 Growth In Imaging-Guided Biopsy Systems
    • 4.2.4 Expansion Of Breast Cancer Diagnostic And Screening Programs
    • 4.2.5 Enhanced Focus On Patient Safety And Sample Accuracy

5. Breast Biopsy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Diagnostic Centers
  • 5.4 Research Laboratories
  • 5.5 Oncology Centers

6. Breast Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Breast Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Breast Biopsy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Breast Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Breast Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Biopsy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Biopsy Market Segmentation

  • 9.1. Global Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
  • 9.2. Global Breast Biopsy Market, Segmentation By Image Guided Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
  • 9.3. Global Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
  • 9.4. Global Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Diagnostic Centers, Other Applications
  • 9.5. Global Breast Biopsy Market, Sub-Segmentation Of Biopsy Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
  • 9.6. Global Breast Biopsy Market, Sub-Segmentation Of Guidance Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
  • 9.7. Global Breast Biopsy Market, Sub-Segmentation Of Biopsy Tables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
  • 9.8. Global Breast Biopsy Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
  • 9.9. Global Breast Biopsy Market, Sub-Segmentation Of Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
  • 9.10. Global Breast Biopsy Market, Sub-Segmentation Of Liquid Biopsy Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
  • 9.11. Global Breast Biopsy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems

10. Breast Biopsy Market Regional And Country Analysis

  • 10.1. Global Breast Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Breast Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Biopsy Market

  • 11.1. Asia-Pacific Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Biopsy Market

  • 12.1. China Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Biopsy Market

  • 13.1. India Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Biopsy Market

  • 14.1. Japan Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Biopsy Market

  • 15.1. Australia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Biopsy Market

  • 16.1. Indonesia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Biopsy Market

  • 17.1. South Korea Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Biopsy Market

  • 18.1. Taiwan Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Biopsy Market

  • 19.1. South East Asia Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Biopsy Market

  • 20.1. Western Europe Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Biopsy Market

  • 21.1. UK Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Biopsy Market

  • 22.1. Germany Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Biopsy Market

  • 23.1. France Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Biopsy Market

  • 24.1. Italy Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Biopsy Market

  • 25.1. Spain Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Biopsy Market

  • 26.1. Eastern Europe Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Biopsy Market

  • 27.1. Russia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Biopsy Market

  • 28.1. North America Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Biopsy Market

  • 29.1. USA Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Biopsy Market

  • 30.1. Canada Breast Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Biopsy Market

  • 31.1. South America Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Biopsy Market

  • 32.1. Brazil Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Biopsy Market

  • 33.1. Middle East Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Biopsy Market

  • 34.1. Africa Breast Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Biopsy Market Regulatory and Investment Landscape

36. Breast Biopsy Market Competitive Landscape And Company Profiles

  • 36.1. Breast Biopsy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Breast Biopsy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Breast Biopsy Market Company Profiles
    • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton Dickinson and Company BD Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke Philips Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. GE HealthCare Technologies Inc Overview, Products and Services, Strategy and Financial Analysis

37. Breast Biopsy Market Other Major And Innovative Companies

  • Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation

38. Global Breast Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Biopsy Market

40. Breast Biopsy Market High Potential Countries, Segments and Strategies

  • 40.1 Breast Biopsy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Breast Biopsy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Breast Biopsy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer